Summary In summary, Semaglutide, as a research product, exhibits potential benefits in improving blood glucose levels, exploring its role as a potential weight loss medication, and investigating its impact on brain cell function
doi: 10.1016/j.molmet.2014.04.009 112 Russell-JonesDVaagASchmitzOSethiBKLalicNAnticSet al
Promising results have been observed for the GLP-1/GIP agonist LY3298176 in overweight or obese people with T2D, noting a weight loss between 0.9 and 11.3 kg in participants using the dual agent compared with 0.4 kg and 2.7 kg in those using placebo or dulaglutide respectively [52]
If you have been advised to self-monitor your blood glucose or have access to testing as part of your care plan, regular monitoringparticularly during the initial weeks of treatment or following dose increasescan help identify patterns and guide management adjustments
Furthermore, pro-inflammatory and pro-fibrotic cytokines, including activin A, visfatin, transforming growth factor-1 (TGF-1), and MCP-1, promote fibroblast proliferation and myofibroblast activation, resulting in atrial and ventricular arrhythmias (103)
